RESUMO
The neurocranium in birds provides valuable insights into their morphological diversity, including adaptations related to brain size, facial shaping, and environmental factors. This study analyzes the neurocranial shape characteristics and size of chickens with similar genetic backgrounds. By examining the neurocranial shape variation in chickens of the same age and sex, the study aims to understand the factors contributing to morphological diversity within this specific group. 3D geometric morphometrics was used to analyze 235 neurocrania from four chicken breeds. The analysis revealed significant differences in centroid size among the chicken breeds. The largest neurocranium centroid size was found in Sasso chickens., which were statistically separated from Atak-S. Additionally, centroid size effectively differentiates between Lohmann Brown and Lohmann Sandy chicken breeds. The most significant shape variation concerned the width of the rostral part of the frontal bone. However, according to the PC1 value, the shape variation was observed within rather than between groups. Lohmann Sandy chickens exhibited higher variability in neurocranial shape, suggesting greater shape diversity within this breed than others. As for shape analysis, the breeds showed closer similarity to each other. Lohmann Sandy chickens are characterized by positive PC1 value, with the rostral end of the frontal region inclined more ventrally, and a more extensive basioccipital region. Sasso chickens have a more dome-shaped middle part of the frontal region than other breeds. The study also identified the most significant shape variation among the study samples, observed at the rostral part of the frontal bone. These findings contribute to understanding the genetic and environmental influences shaping neurocranial morphology in chickens. Similar studies in different bird species and subspecies offer valuable insights into avian biology and adaptation.
RESUMO
INTRODUCTION AND HYPOTHESIS: This study aims to compare the effectiveness of intravaginal electrical stimulation (IVES) with regard to quality of life (QoL) and clinical parameters related to incontinence in women with idiopathic overactive bladder (iOAB) naive or refractory to treatment with pharmacological agents (PhA). METHODS: In this prospective trial, PhA-naive women were included in Group 1 (n = 24) and women with PhA-resistant iOAB were included in Group 2 (n = 24). IVES was performed 3 days a week, with a total of 24 sessions for 8 weeks. Every session lasted 20 minutes. Women were evaluated for the severity of incontinence (24-hour pad test), pelvic floor muscle (PFM) strength (perineometer), 3-day voiding diary (frequency of voiding, nocturia, incontinence episodes, and the number of pads), symptom severity (OAB-V8), quality of life (IIQ-7), treatment success (positive response rate), cure/improvement rate, and treatment satisfaction. RESULTS: A statistically significant improvement was found in all parameters for each group at the 8th week compared to the baseline values (p < 0.05). At the 8th week, there were no statistically significant differences in the severity of incontinence, PFM strength, incontinence episodes, nocturia, number of pads, QoL, treatment satisfaction, cure-improvement, or positive response rates between the two groups (p > 0.05). It was found that the frequency of voiding and symptom severity parameters were significantly more improved in Group 1 than in Group 2 (p < 0.05). CONCLUSIONS: Although IVES was more effective in PhA-naive women with iOAB, it also appears to be an effective treatment in the management of women with PhA-resistant iOAB. CLINICAL TRIAL REGISTRATION: This study was registered with ClinicalTrials.gov under no. NCT05416450.
